Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients by Shah, V, Sherborne, AL, Johnson, DC, Ellis, S, Price, A, Chowdhury, F, Kendall, J, Jenner, MW, Drayson, MT, Owen, RG, Gregory, WM, Morgan, GJ, Davies, FE, Cook, G, Cairns, DA, Houlston, RS, Jackson, G, Kaiser, MF, NCRI Haematology Clinical Studies Group